The Effect of Nopalea™, a Nutritional Supplement Containing Cactus Fruit Juice, on C-Reactive Protein Levels in Healthy Adults Assessed using a Randomized, Double-Blind, and Controlled Experimental Design by Tsnobiladze, Medeya et al.
The Effect of Nopalea™, a Nutritional Supplement 
Containing Cactus Fruit Juice, on C-Reactive Protein 
Levels in Healthy Adults Assessed using a 
Randomized, Double-Blind, and Controlled 
Experimental Design 
Medeya Tsnobiladze, ND, Patricia Diefenbach, Sarwat Patel,Cynthia 
Schmeck, and Mark Mattie, MD, Ph.D. 
Abstract 
Objective:  
 
This study was developed to investigate 
the anti-inflammatory effects of a 
commercial product (Nopalea™) 
containing Prickly Pear Cactus Fruit Juice 
in 286 healthy adults. The research 
method employed was a double blind, 
placebo controlled, and time-series 
design with C-Reactive Protein (CRP) 
serving as a marker for inflammation. 
CRP levels were measured at baseline as 
well as at eight weeks and 12 weeks post-
treatment. 
 
Design:  
 
A total of 286 men and women, between 
35-75 years of age, were recruited, 
screened, and randomly assigned to an 
experimental group (145 subjects) and a 
placebo group (141 subjects).  All 
participants were recruited via IRB-
approved advertisement . 
 
Participants were required to attend an 
orientation seminar. At this time, a blood 
sample was obtained to establish 
baseline CRP levels. Subjects were 
provided with either Nopalea or apricot 
juice and instructed to ingest six fluid 
ounces of fruit juice daily.  
 
Subjects were required to return to the 
trial center to obtain blood samples at 
eight weeks and 12 weeks following 
implementation of the protocol. 
 
Protocol:  
 
Inclusion criteria: 
• Live within traveling distance of the 
research and blood drawing centers. 
• Access to a telephone in their 
residence.  
• Between 35 and 75 years of age 
• Must sign an informed consent form 
• Blood CRP levels must remain at or 
below 3mg/L throughout the entire study 
  
Exclusion criteria: 
• Currently ingesting Nopalea 
• Pregnant, planning to become 
pregnant, or nursing a child 
• Currently taking anti-inflammatory 
medications 
• On hormone replacement therapy or 
birth control medication 
• Medically unstable – i.e., recent major 
change in the last three weeks of 
prescription or non- prescription 
medication  
• Diagnosed with type I or II Diabetes 
• Diagnosed with depression 
• Diagnosed with an acquired or 
congenital immune system deficiency 
• Has had surgery within 30 days 
• Has unstable angina 
• Had a stroke within the last six months 
• Clinically overt peripheral vascular 
disease 
• Diagnosed or demonstrates symptoms 
consistent with congestive heart failure 
Results: 
  
A total of 286 subjects began the 
study, including 145 and 141 
participants assigned to the 
experimental group and control group, 
respectively.  A total of 18 people 
dropped out for various reasons, 16 
from the apricot group and two from 
the Nopalea group. 
  
Blood concentrations of CRP in 
participants ingesting Nopalea were 
reduced by an average of 20.9% over 
a period of eight weeks. This effect 
diminished with time in that CRP levels 
were reduced by only 10.5% 
compared to baseline at12 weeks (see 
Table 1). At both eight and 12 week 
assessments, these reductions were 
statistically significant (p<0.05). 
  
Blood concentrations of CRP in 
participants ingesting apricot juice 
were reduced by an average of 7.9% 
over a period of eight weeks (see 
Table 2). By 12 weeks, this effect 
diminished and CRP levels were only 
3.1% less than those at baseline. At 
both eight and 12 week assessments, 
these reductions were not statistically 
significant (p>0.05). 
 
Conclusions:  
 
This study demonstrated that eight 
week supplementation with  6oz of 
Nopalea results in a statistically 
significant decrease in CRP in healthy 
subjects with levels of CRP under 
3mg/L.  
 
The results seem to support the 
potential use of the Nopalea product 
as a modulator of inflammation in 
healthy individuals that allows for good 
compliance. However, it remains 
uncertain to what degree and for what 
duration this fruit juice-induced 
reduction in inflammation has, long 
term, on morbidity and mortality. 
Materials & Methods 
Results & Conclusions 
Samples: 
• Blood samples from subjects were 
obtained by LabCorp, inc. (3271 N 
Civic Center PLZ STE 9 Scottsdale, 
AZ 85251) phlebotomy technicians 
and were taken directly to LabCorp 
facilities for analysis.  
